Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3
Completed · Not applicable
Conditions studied: Alzheimer's Disease, Mild Cognitive Impairment
In brief
Investigate the long-term impact of amount and duration of Tailored Lighting Intervention (TLI) obtained from Aims 1 and 2 on sleep, cognition, circadian marker, mood, and behavior in AD/ADRD patients. For this single-arm, randomized, placebo-controlled study, the researchers plan to recruit 100 participants who will experience either the active TLI or the placebo for 6 months.
Key facts
- Study ID
- NCT06595030
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 101
- Starts
- 2024-12-03
- Expected to finish
- 2026-01-31
- Last updated by the study team
- 2026-02-17
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of Alzheimer's disease or related dementia with a Montreal Cognitive Assessment score <25
- Sleep disturbance with a Pittsburgh Sleep Quality Index score ≥5
You may not qualify if…
- Extensive brain vascular disease, traumatic brain injury, multiple sclerosis, Parkinson's Disease
- Obstructing cataracts
- Severe macular degeneration
- Use of sleep medication
- Use of oral melatonin
- untreated moderate to severe sleep apnea
- Severe restless leg syndrome - Blindness
Where it is running
- Icahn School of Medicine at Mount Sinai — Menands, New York, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.